Literature DB >> 7916726

HIV1 integrase expressed in Escherichia coli from a synthetic gene.

T P Holler1, S K Foltin, Q Z Ye, D J Hupe.   

Abstract

Human immunodeficiency virus type 1 (HIV1) integrase is cleaved from the gag-pol precursor by the HIV1 protease. The resulting 32-kDa protein is used by the infecting virus to insert a linear, double-stranded DNA copy of its genome, prepared by reverse transcription of viral RNA, into the host cell's chromosomal DNA. In order to achieve high levels of expression, to minimize an internal initiation problem and to facilitate mutagenesis, we have designed and synthesized a gene encoding the integrase from the infectious molecular clone, pNL4-3. Codon usage was optimized for expression in Escherichia coli and unique restriction sites were incorporated throughout the gene. A 905-bp cassette containing a ribosome-binding site, a start codon and the integrase-coding sequence, sandwiched between EcoRI and HindIII sites, was synthesized by overlap extension of nine long synthetic oligodeoxyribonucleotides [90-120 nucleotides (nt)] and subsequent amplification using two primers (28-30 nt). The cassette was subcloned into the vector pKK223-3 for expression under control of a tac promoter. The protein produced from this highly expressed gene has the expected N-terminal sequence and molecular mass, and displays the DNA processing, DNA joining and disintegration activities expected from recombinant integrase. These studies have demonstrated the utility of codon optimization, and lay the groundwork for structure-function studies of HIV1 integrase.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7916726     DOI: 10.1016/0378-1119(93)90488-o

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  9 in total

1.  Computational design of a full-length model of HIV-1 integrase: modeling of new inhibitors and comparison of their calculated binding energies with those previously studied.

Authors:  Selami Ercan; Necmettin Pirinccioglu
Journal:  J Mol Model       Date:  2013-08-02       Impact factor: 1.810

2.  Interaction of recombinant Tetrahymena telomerase proteins p80 and p95 with telomerase RNA and telomeric DNA substrates.

Authors:  L Gandhi; K Collins
Journal:  Genes Dev       Date:  1998-03-01       Impact factor: 11.361

3.  Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase.

Authors:  P Levy-Mintz; L Duan; H Zhang; B Hu; G Dornadula; M Zhu; J Kulkosky; D Bizub-Bender; A M Skalka; R J Pomerantz
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

4.  The human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein zinc ejection activity of disulfide benzamides and benzisothiazolones: correlation with anti-HIV and virucidal activities.

Authors:  P J Tummino; P J Harvey; T McQuade; J Domagala; R Gogliotti; J Sanchez; Y Song; D Hupe
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

5.  Model of full-length HIV-1 integrase complexed with viral DNA as template for anti-HIV drug design.

Authors:  Rajeshri G Karki; Yun Tang; Terrence R Burke; Marc C Nicklaus
Journal:  J Comput Aided Mol Des       Date:  2005-06-27       Impact factor: 3.686

6.  The in vitro ejection of zinc from human immunodeficiency virus (HIV) type 1 nucleocapsid protein by disulfide benzamides with cellular anti-HIV activity.

Authors:  P J Tummino; J D Scholten; P J Harvey; T P Holler; L Maloney; R Gogliotti; J Domagala; D Hupe
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

7.  Independently inducible system of gene expression for condensed single protein production (cSPP) suitable for high efficiency isotope enrichment.

Authors:  William M Schneider; Masayori Inouye; Gaetano T Montelione; Monica J Roth
Journal:  J Struct Funct Genomics       Date:  2009-07-30

8.  Soluble Expression and Catalytic Properties of Codon-Optimized Recombinant Bromelain from MD2 Pineapple in Escherichia coli.

Authors:  Rafida Razali; Cahyo Budiman; Khairul Azfar Kamaruzaman; Vijay Kumar Subbiah
Journal:  Protein J       Date:  2021-03-13       Impact factor: 2.371

9.  Expression of human nPTB is limited by extreme suboptimal codon content.

Authors:  Fiona Robinson; Richard J Jackson; Christopher W J Smith
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.